These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 24656004)
1. Association between use of FK506 and prevalence of post-transplantation diabetes mellitus in kidney transplant patients. Weng LC; Chiang YJ; Lin MH; Hsieh CY; Lin SC; Wei TY; Chou HF Transplant Proc; 2014; 46(2):529-31. PubMed ID: 24656004 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Tacrolimus Trough Level in Patients Who Developed Post-transplant Diabetes Mellitus After Kidney Transplantation: A Retrospective Single-Center Study in Saudi Arabia. Ajabnoor A; Nasser M; Khan N; Habhab W Transplant Proc; 2020 Dec; 52(10):3160-3167. PubMed ID: 32636070 [TBL] [Abstract][Full Text] [Related]
3. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy. Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910 [TBL] [Abstract][Full Text] [Related]
4. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients. Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487 [TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic risk factors for posttransplant diabetes mellitus in adult renal transplant recipients treated with tacrolimus. Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Matsuura S; Saito M; Tada H; Suzuki T; Habuchi T Transplantation; 2005 Nov; 80(10):1419-24. PubMed ID: 16340785 [TBL] [Abstract][Full Text] [Related]
6. Insulin Secretion and Insulin Resistance Trajectories over 1 Year after Kidney Transplantation: A Multicenter Prospective Cohort Study. Bang JB; Oh CK; Kim YS; Kim SH; Yu HC; Kim CD; Ju MK; So BJ; Lee SH; Han SY; Jung CW; Kim JK; Lee SH; Jeon JY Endocrinol Metab (Seoul); 2020 Dec; 35(4):820-829. PubMed ID: 33202516 [TBL] [Abstract][Full Text] [Related]
7. Post-Transplant Diabetes Mellitus After Kidney Transplant in Hispanics and Caucasians Treated with Tacrolimus-Based Immunosuppression. Baron PW; Infante S; Peters R; Tilahun J; Weissman J; Delgado L; Kore AH; Beeson WL; de Vera ME Ann Transplant; 2017 May; 22():309-314. PubMed ID: 28533501 [TBL] [Abstract][Full Text] [Related]
8. Higher initial tacrolimus blood levels and concentration-dose ratios in kidney transplant recipients who develop diabetes mellitus. Rodrigo E; de Cos MA; Fernández-Fresnedo G; Sánchez B; Ruiz JC; Piñera C; Palomar R; Cotorruelo JG; Gómez-Alamillo C; de Castro SS; de Francisco AL; Arias M Transplant Proc; 2005 Nov; 37(9):3819-20. PubMed ID: 16386549 [TBL] [Abstract][Full Text] [Related]
9. Incidence and Risk Factors of Posttransplantation Diabetes Mellitus in Living Donor Kidney Transplantation: A Single-Center Retrospective Study in China. Xu J; Xu L; Wei X; Li X; Cai M Transplant Proc; 2018 Dec; 50(10):3381-3385. PubMed ID: 30471834 [TBL] [Abstract][Full Text] [Related]
10. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. Bloom RD; Rao V; Weng F; Grossman RA; Cohen D; Mange KC J Am Soc Nephrol; 2002 May; 13(5):1374-80. PubMed ID: 11961026 [TBL] [Abstract][Full Text] [Related]
11. Modifiable Variables Are Major Risk Factors for Posttransplant Diabetes Mellitus in a Time-Dependent Manner in Kidney Transplant: An Observational Cohort Study. de Lucena DD; de Sá JR; Medina-Pestana JO; Rangel ÉB J Diabetes Res; 2020; 2020():1938703. PubMed ID: 32258163 [TBL] [Abstract][Full Text] [Related]
12. Prevalence and long-term glucose metabolism evolution of post-transplant diabetes mellitus in Chinese renal recipients. Xu Y; Liang JX; Liu B; Yao B; Pokharel S; Chen GD; Wang CX; Li YB; Xiao HP Diabetes Res Clin Pract; 2011 Apr; 92(1):11-8. PubMed ID: 21236511 [TBL] [Abstract][Full Text] [Related]
13. Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study. van der Burgh AC; Moes A; Kieboom BCT; van Gelder T; Zietse R; van Schaik RHN; Hesselink DA; Hoorn EJ Nephrol Dial Transplant; 2020 Jan; 35(1):176-183. PubMed ID: 31361318 [TBL] [Abstract][Full Text] [Related]
14. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism. Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298 [TBL] [Abstract][Full Text] [Related]
15. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study. Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169 [TBL] [Abstract][Full Text] [Related]
16. Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation. Jehn U; Wiedmer N; Boeckel GR; Pavenstädt H; Thölking G; Reuter S Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012395 [TBL] [Abstract][Full Text] [Related]